Grunenthal Ltd. develops, manufactures, and distributes pharmaceutical products. The Company markets its products to healthcare providers, clinics, researchers, and facilities throughout the United Kingdom and internationally.
Every round, secondary, debt facility or acquisition involving Grünenthal that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.